No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

KA Imaging Appoints World-Renowned Radiologist, Dr. Philip Templeton, as Chief Medical Officer

Editor: What To Know

  • “In addition to being a skilled physician, Philip is a seasoned corporate leader with a strong track record of delivering medical, scientific and strategic guidance to both established and emerging companies in the medical imaging space,” said Amol Karnick, CEO of KA Imaging.
  • Shawn Campbell as Vice President of Operations and Robert Moccia as Vice President of Sales, USA and Canada – as KA Imaging executes its commercial roll-out of Reveal™ 35C, the world's first portable, single exposure, dual-energy X-ray detector that enables bone and soft tissue differentiation without motion artifacts.
  • A graduate and valedictorian at the University of Rochester School of Medicine, he did his internship in Medicine at the Georgetown University Hospital.

March 8, 2021

KA Imaging notes Dr. Philip Templeton brings over 38 years of academic and entrepreneurial medicine experience to KA Imaging.

Dr. Philip Templeton is most recently known as Cofounder and Chief Medical Officer of DocPanel Technologies. A graduate and valedictorian at the University of Rochester School of Medicine, he did his internship in Medicine at the Georgetown University Hospital. His radiology residency was at the University of Maryland, where he also served as Chief Resident. He undertook his Thoracic Radiology Fellowship at the Massachusetts General Hospital. He served as Professor and Chairman of University of Maryland Radiology for ten years.  Dr. Templeton was inducted as a Fellow of the American College of Radiology in 2000.

Among his many career accomplishments, Dr. Templeton was a pioneer in the use of several groundbreaking technologies, including CT fluoroscopy, digital X-ray, PACS and teleradiology.

“In addition to being a skilled physician, Philip is a seasoned corporate leader with a strong track record of delivering medical, scientific and strategic guidance to both established and emerging companies in the medical imaging space,” said Amol Karnick, CEO of KA Imaging. “We are delighted to welcome him as CMO. Philip will provide a strong liaison with our customers, and ensure that our clinical programs are designed to meet the needs of both clinicians and patients.”

Dr. Templeton’s appointment comes on the heels of the recent additions of two other seasoned industry veterans – Shawn Campbell as Vice President of Operations and Robert Moccia as Vice President of Sales, USA and Canada – as KA Imaging executes its commercial roll-out of Reveal™ 35C, the world’s first portable, single exposure, dual-energy X-ray detector that enables bone and soft tissue differentiation without motion artifacts.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy